Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma
Background and Objectives. The aim of the study was to determine systemic and fecal values of galectin-3 and pro- and anti-inflammatory cytokines in patients with CRC and the relationship with clinicopathological aspects. Methods. Concentrations of galectin-3, TNF-α, TGF-β, IL-10, and IL-1β were ana...
Saved in:
| Main Authors: | Milan Jovanovic, Nevena Gajovic, Natasa Zdravkovic, Marina Jovanovic, Milena Jurisevic, Danilo Vojvodic, Veljko Maric, Aleksandar Arsenijevic, Ivan Jovanovic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/8031328 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal galectin-1 as a potential marker for colorectal cancer and disease severity
by: Jovanović Milan, et al.
Published: (2019-01-01) -
Fecal sST2 correlates with the disease severity of ulcerative colitis
by: Jovanović Marina, et al.
Published: (2019-01-01) -
Colorectal carcinoma: Evaluation of systemic values of interleukin-1 and interleukin-33 in patients with and without thrombocytosis
by: Jocić Miodrag, et al.
Published: (2021-01-01) -
Anti-PD-1 therapy activates tumoricidic properties of NKT cells and contributes to the overall deceleration of tumor progression in a model of murine mammary carcinoma
by: Jovanović Marina, et al.
Published: (2022-01-01) -
IL-32 expression associated with lymph vessel invasion in intestinal type of gastric cancer
by: Pavlović Mladen, et al.
Published: (2020-01-01)